15 Mar 2023 ADOCIA announces its annual results for 2022 and provides corporate and financial update Icon check
15 Feb 2023 Number of shares and voting rights of ADOCIA as of January 31st, 2023 Icon check
30 Jan 2023 ADOCIA publishes its Letter to Shareholders Icon check
16 Jan 2023 Number of shares and voting rights of ADOCIA as of December 31st, 2022 Icon check
12 Jan 2023 ADOCIA Announces its financial calendar for 2023 Icon check
12 Jan 2023 A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes Obes Metab., 2023;25(5):1241-1248.
29 Dec 2022 ADOCIA Announces the Successful Phase 1 Study for BioChaperone庐 Lispro with Partner Tonghua Dongbao Icon check
21 Dec 2022 ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2023 Icon check
15 Dec 2022 Number of shares and voting rights of ADOCIA as of November 30th, 2022 Icon check
01 Dec 2022 黑料网 strengthens its cash position with EUR 6 million through the issuance of convertible bonds subscribed by European investors in order to accelerate the development of key products Icon check
16 Nov 2022 Number of shares and voting rights of ADOCIA as of October 31st, 2022 Icon check
25 Oct 2022 ADOCIA Reports its Cash Position and Revenue for the Third Quarter of 2022 and Provides Business Updates Icon check
13 Oct 2022 Number of shares and voting rights of ADOCIA as of September 30th, 2022 Icon check
06 Oct 2022 ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a post-hoc analysis Icon check
03 Oct 2022 ADOCIA: Upcoming investor meetings Icon check
Investors Webinar of Sept 20th, 2022
19 Sep 2022 ADOCIA Announces First Half 2022 Financial Results and Provides a Business Update Icon check
15 Sep 2022 ADOCIA Will Release its 2022 Half-Year Results on September 19th and Hold a Webinar on September 20th Icon check
14 Sep 2022 Number of shares and voting rights of ADOCIA as of August 31st, 2022 Icon check
07 Sep 2022 ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell庐 Islets for the Treatment of Type 1 Diabetes Icon check
2022 AdoShell Islets Presentation
25 Aug 2022 Number of shares and voting rights of ADOCIA as of July 31st, 2022 Icon check
24 Aug 2022 ADOCIA Reports Cash and Revenue for the Second Quarter and Provides Corporate Update Icon check
11 Jul 2022 Number of shares and voting rights of ADOCIA as of June 30th, 2022 Icon check
23 Jun 2022 黑料网 publishes its Letter to Shareholders Icon check
21 Jun 2022 ADOCIA announces M1Pram Phase 2 Trial Meets Primary Objective by Reducing Weight in Overweight People with Type 1 Diabetes Icon check
14 Jun 2022 Number of shares and voting rights of ADOCIA as of May 31st, 2022 Icon check
20 May 2022 ADOCIA Announces its annual Shareholders鈥� meeting to be held on June 28, 2022 in Paris Icon check
18 May 2022 ADOCIA Reports Financial Results of First Quarter 2022 and Provides Corporate Update Icon check
18 May 2022 ADOCIA Announces The First Subject Treated In BioChaperone庐 Combo Clinical Studies with Partner Tonghua Dongbao Icon check
13 May 2022 Number of shares and voting rights of ADOCIA as of April 30th, 2022 Icon check
09 May 2022 ADOCIA Announces the First Patient Dosed In the BioChaperone庐 Lispro Phase 3 Program with Partner Tonghua Dongbao Icon check
25 Apr 2022 ADOCIA Announces the Release of its Universal Registration Document for the Year 2021 Icon check
19 Apr 2022 ADOCIA announces its annual results for 2021 and presents an update on activities Icon check
15 Apr 2022 Number of shares and voting rights of ADOCIA as of March 31st, 2022 Icon check
11 Apr 2022 ADOCIA Announces Start of 3 Clinical Studies for BioChaperone庐 Combo with Partner Tonghua Dongbao Icon check
28 Mar 2022 黑料网 strengthens its cash position by 19 million euros following a real estate transaction Icon check
16 Mar 2022 Number of shares and voting rights of ADOCIA as of February 28th, 2022 Icon check
23 Feb 2022 ADOCIA announces 2021 fourth quarter financial results Icon check
15 Feb 2022 Number of shares and voting rights of ADOCIA as of January 31st, 2021 Icon check
11 Jan 2022 Number of shares and voting rights of ADOCIA as of December 31st, 2021 Icon check
06 Jan 2022 ADOCIA announces its financial calendar for 2022 Icon check
20 Dec 2021 ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022 Icon check
15 Dec 2021 Number of shares and voting rights of ADOCIA as of November 30th, 2021 Icon check
13 Dec 2021 黑料网 Files Patent for Technology to Enable Oral Drug Delivery of Peptides Icon check
19 Nov 2021 Number of shares and voting rights of ADOCIA as of October 31st, 2021 Icon check
26 Oct 2021 黑料网 announces 2021 third quarter financial results and a financing of 鈧�7 million Icon check
14 Oct 2021 ADOCIA鈥檚 partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone庐 Lispro Phase 3 Trial in China Icon check
12 Oct 2021 Number of shares and voting rights of ADOCIA as of September 30th, 2021 Icon check
21 Sep 2021 ADOCIA announces Oral Presentation Reviewing M1Pram (ADO09) at the occasion of the 57th Annual Meeting of EASD Icon check
Join our mailing list. Subscribe